| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 3.18▲ | 3.18▲ | 3.17▲ | 3.10▲ | 3.34▼ |
| MA10 | 3.18▲ | 3.16▲ | 3.13▲ | 3.12▲ | 3.61▼ |
| MA20 | 3.18▲ | 3.12▲ | 3.11▲ | 3.36▼ | 3.83▼ |
| MA50 | 3.16▲ | 3.12▲ | 3.10▲ | 3.66▼ | 4.08▼ |
| MA100 | 3.13▲ | 3.09▲ | 3.27▼ | 3.80▼ | 4.57▼ |
| MA200 | 3.11▲ | 3.31▼ | 3.40▼ | 3.80▼ | 4.63▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.002▲ | 0.009▲ | 0.013▲ | -0.009▼ | -0.071▼ |
| RSI | 69.012▲ | 68.218▲ | 64.185▲ | 43.441▼ | 42.929▼ |
| STOCH | 68.750 | 78.989 | 85.702▲ | 35.751 | 18.301▼ |
| WILL %R | 0.000▲ | 0.000▲ | 0.000▲ | -67.708 | -79.333▼ |
| CCI | 292.337▲ | 112.450▲ | 139.016▲ | -39.368 | -136.655▼ |
|
Tuesday, October 20, 2026 01:03 PM
Chief Executive Officer Mike Castagna said the company is advancing an inhaled version of nintedanib into a global Phase 2 study for idiopathic pulmonary fibrosis, or IPF, following early safety and t ...
|
|
Tuesday, October 20, 2026 01:03 PM
Chief Executive Officer Mike Castagna said the company is advancing an inhaled version of nintedanib into a global Phase 2 study for idiopathic pulmonary fibrosis, or IPF, following early safety and t ...
|
|
Tuesday, October 20, 2026 07:00 AM
MannKind reported new clinical data for Furoscix ReadyFlow, showing IV-equivalent exposure and diuretic effect across thigh and upper arm injection sites in adults with heart failure or chronic kidney ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 22/10/26 | 3.02 | 3.21 | 3.01 | 3.21 | 2,729,233 |
| 21/10/26 | 3.10 | 3.13 | 3.04 | 3.05 | 2,794,979 |
| 20/10/26 | 3.11 | 3.18 | 3.08 | 3.10 | 2,167,663 |
| 19/10/26 | 3.18 | 3.22 | 3.07 | 3.09 | 2,463,015 |
| 16/10/26 | 3.20 | 3.24 | 3.02 | 3.04 | 2,604,412 |
| 15/10/26 | 3.02 | 3.20 | 3.00 | 3.19 | 3,756,500 |
| 14/10/26 | 3.00 | 3.13 | 2.90 | 3.02 | 7,933,900 |
| 13/10/26 | 3.13 | 3.14 | 3.02 | 3.05 | 4,385,382 |
| 12/10/26 | 3.24 | 3.27 | 3.08 | 3.13 | 3,957,000 |
| 09/10/26 | 3.40 | 3.405 | 3.23 | 3.29 | 4,549,647 |
|
|
||||
|
|
||||
|
|